Clinical Trials Directory

Trials / Completed

CompletedNCT01402830

Case-control Study- Cancer Pain: Uncontrolled Pain as Depression Development Predictor in Oncologic Patients (Fentanyl)

DPRESS Study. Case-control Study in Cancer Pain: Uncontrolled Pain as Depression Development Predictor in Oncologic Patients

Status
Completed
Phase
Study type
Observational
Enrollment
271 (actual)
Sponsor
Janssen-Cilag, S.A. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the relationship between cancer pain and risk of depression among cancer patients.

Detailed description

This is a retrospective observational and case-control multicenter study. The main objective of this study is determine the degree of association between cancer pain and depression by impact assessment of adequate control of pain associated with cancer risk depression in patients attending the Oncology Unit. The assessment of pain intensity will be performed by using visual analogue scales (EVAs) and verbal descriptive scales, as an observational study, not limit or modify the use of any drug. The patients included in this study have a medical history of cancer pain and mild depression (Beck = 8). The controls are patients with history of cancer pain and mild or absent depression (Beck = 7). n/a

Conditions

Interventions

TypeNameDescription
OTHERVisual analogue scales (EVAs)This scale measures the pain intensity.

Timeline

Start date
2007-11-01
Primary completion
2008-03-01
Completion
2008-03-01
First posted
2011-07-26
Last updated
2013-02-11

Source: ClinicalTrials.gov record NCT01402830. Inclusion in this directory is not an endorsement.

Case-control Study- Cancer Pain: Uncontrolled Pain as Depression Development Predictor in Oncologic Patients (Fentanyl) (NCT01402830) · Clinical Trials Directory